MCD vs NVDA: Which Is the Better Buy?

Side-by-side comparison of McDonald's Corporation and NVIDIA Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-20.
McDonald's Corporation Β· Consumer Cyclical
$267.71
+20.6% upside to fair value
Med Conviction Grade C+ High Quality
VS
NVIDIA Corporation Β· Technology
$210.69
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
NVDA has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MCD NVDA
Current Price $267.71 $210.69
Fair Value Estimate $322.85 $305.50
Upside to Fair Value +20.6% +45.0%
Market Cap $190.2B $5,103.1B
Forward P/E β€” 32.1x
EV / EBITDA 16.4x 26.5x
Price / Sales 6.9x 20.1x
Price / FCF 27.0x 42.9x
Revenue Growth YoY +9.4% +85.2%
Gross Margin 57.4% 74.1%
Operating Margin 46.0% 64.0%
Return on Equity -433.9% 111.7%
Dividend Yield 2.75% 0%
FCF Yield 3.7% 2.33%
Analyst Consensus Buy Strong Buy
Investment Thesis
MCD β€” McDonald's Corporation
McDonald's is a global quick-service restaurant franchisor and real-estate platform whose approximately 95% franchised restaurant base generates unusually high-margin, recurring royalty and rent income, supporting a 46.0% operating margin and 31.6% net margin. Business quality is high because its brand, global purchasing scale, nearly 29,000 drive-thrus, digital ecosystem and 210 million 90-day a…
NVDA β€” NVIDIA Corporation
NVIDIA Corporation is a leading technology company specializing in semiconductors, particularly GPUs and AI accelerators, with a dominant market position in AI training markets holding over 80% share. The company exhibits exceptional business quality with a founder-led management team boasting over 30 years of continuous leadership, very high profitability with gross margins above 74% and net mar…
Accumulation Zones
Metric MCD NVDA
Zone Low $242.14 $229.12
Zone High $274.42 $259.68
In Buy Zone? Yes Yes
← MCD Research    NVDA Research β†’    All Research